(COHR) Coherent - Ratings and Ratios
Transceivers, Laser, Materials, Optics, Subsystems
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 65.7% |
| Value at Risk 5%th | 96.2% |
| Relative Tail Risk | -10.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.19 |
| Alpha | 51.15 |
| CAGR/Max DD | 1.44 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.506 |
| Beta | 2.507 |
| Beta Downside | 2.710 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.85% |
| Mean DD | 17.37% |
| Median DD | 14.49% |
Description: COHR Coherent December 19, 2025
Coherent Corp. (NYSE:COHR) designs, manufactures, and sells engineered materials, optoelectronic components, and laser systems that serve industrial, communications, electronics, and instrumentation markets worldwide. The business is organized into three segments: Networking (data-center transceivers, optics, and semiconductor devices), Materials (engineered ceramics, metal-matrix composites, and laser optics), and Lasers (excimer, solid-state, CO₂, and high-power lasers for semiconductor equipment, display and precision manufacturing, and scientific research). Sales are executed through a mix of direct forces, representatives, and distributors. The company, formerly II-VI Incorporated, rebranded to Coherent Corp. in September 2022 and is headquartered in Saxonburg, Pennsylvania.
Key recent metrics show FY 2023 revenue of roughly $1.3 billion, with the Laser segment posting a 12 % year-over-year growth driven by rising demand for high-power tools in semiconductor fab upgrades. Gross margins have stabilized near 45 %, and the firm generated about $150 million of free cash flow, supporting a modest dividend and share-repurchase program. Macro-level drivers include accelerating data-center traffic from AI workloads (boosting the Networking segment) and a global semiconductor cap-ex cycle that sustains laser-tool spend, while supply-chain tightness for semiconductor components remains a near-term risk.
For a deeper quantitative view, you might explore ValueRay’s detailed financial model for COHR.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (249.8m TTM) > 0 and > 6% of Revenue (6% = 362.6m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA -0.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 38.16% (prev 45.42%; Δ -7.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 526.6m > Net Income 249.8m (YES >=105%, WARN >=100%) |
| Net Debt (2.65b) to EBITDA (1.21b) ratio: 2.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.33 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (155.5m) change vs 12m ago 2.54% (target <= -2.0% for YES) |
| Gross Margin 36.01% (prev 32.17%; Δ 3.85pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 41.11% (prev 34.03%; Δ 7.08pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.82 (EBITDA TTM 1.21b / Interest Expense TTM 368.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.60
| (A) 0.16 = (Total Current Assets 4.04b - Total Current Liabilities 1.74b) / Total Assets 14.70b |
| (B) 0.05 = Retained Earnings (Balance) 777.2m / Total Assets 14.70b |
| (C) 0.05 = EBIT TTM 669.3m / Avg Total Assets 14.70b |
| (D) 1.04 = Book Value of Equity 6.24b / Total Liabilities 6.01b |
| Total Rating: 2.60 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.11
| 1. Piotroski 5.0pt |
| 2. FCF Yield 0.22% |
| 3. FCF Margin 1.22% |
| 4. Debt/Equity 0.42 |
| 5. Debt/Ebitda 2.20 |
| 6. ROIC - WACC (= -6.29)% |
| 7. RoE 3.14% |
| 8. Rev. Trend 81.24% |
| 9. EPS Trend 3.47% |
What is the price of COHR shares?
Over the past week, the price has changed by +4.20%, over one month by +30.01%, over three months by +70.31% and over the past year by +93.21%.
Is COHR a buy, sell or hold?
- Strong Buy: 11
- Buy: 5
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the COHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 174.5 | -6.1% |
| Analysts Target Price | 174.5 | -6.1% |
| ValueRay Target Price | 245.3 | 32% |
COHR Fundamental Data Overview December 13, 2025
P/E Trailing = 279.5775
P/E Forward = 30.03
P/S = 5.1619
P/B = 5.3506
P/EG = 0.34
Beta = 1.86
Revenue TTM = 6.04b USD
EBIT TTM = 669.3m USD
EBITDA TTM = 1.21b USD
Long Term Debt = 3.26b USD (from longTermDebt, last quarter)
Short Term Debt = 89.8m USD (from shortTermDebt, last quarter)
Debt = 3.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.65b USD (from netDebt column, last quarter)
Enterprise Value = 33.85b USD (31.19b + Debt 3.51b - CCE 852.8m)
Interest Coverage Ratio = 1.82 (Ebit TTM 669.3m / Interest Expense TTM 368.5m)
FCF Yield = 0.22% (FCF TTM 73.8m / Enterprise Value 33.85b)
FCF Margin = 1.22% (FCF TTM 73.8m / Revenue TTM 6.04b)
Net Margin = 4.13% (Net Income TTM 249.8m / Revenue TTM 6.04b)
Gross Margin = 36.01% ((Revenue TTM 6.04b - Cost of Revenue TTM 3.87b) / Revenue TTM)
Gross Margin QoQ = 36.63% (prev 36.62%)
Tobins Q-Ratio = 2.30 (Enterprise Value 33.85b / Total Assets 14.70b)
Interest Expense / Debt = 1.67% (Interest Expense 58.7m / Debt 3.51b)
Taxrate = -3.83% (negative due to tax credits) (-8.31m / 216.9m)
NOPAT = 694.9m (EBIT 669.3m * (1 - -3.83%)) [negative tax rate / tax credits]
Current Ratio = 2.33 (Total Current Assets 4.04b / Total Current Liabilities 1.74b)
Debt / Equity = 0.42 (Debt 3.51b / totalStockholderEquity, last quarter 8.34b)
Debt / EBITDA = 2.20 (Net Debt 2.65b / EBITDA 1.21b)
Debt / FCF = 35.96 (Net Debt 2.65b / FCF TTM 73.8m)
Total Stockholder Equity = 7.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.70% (Net Income 249.8m / Total Assets 14.70b)
RoE = 3.14% (Net Income TTM 249.8m / Total Stockholder Equity 7.97b)
RoCE = 5.96% (EBIT 669.3m / Capital Employed (Equity 7.97b + L.T.Debt 3.26b))
RoIC = 7.60% (NOPAT 694.9m / Invested Capital 9.15b)
WACC = 13.88% (E(31.19b)/V(34.70b) * Re(15.25%) + D(3.51b)/V(34.70b) * Rd(1.67%) * (1-Tc(-0.04)))
Discount Rate = 15.25% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.29%
[DCF Debug] Terminal Value 56.21% ; FCFE base≈93.6m ; Y1≈93.0m ; Y5≈97.5m
Fair Price DCF = 4.56 (DCF Value 717.4m / Shares Outstanding 157.2m; 5y FCF grow -1.31% → 3.0% )
EPS Correlation: 3.47 | EPS CAGR: 6.38% | SUE: 1.45 | # QB: 2
Revenue Correlation: 81.24 | Revenue CAGR: 19.66% | SUE: 1.83 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.31 | Chg30d=+0.130 | Revisions Net=+15 | Analysts=17
EPS current Year (2026-06-30): EPS=5.06 | Chg30d=+0.463 | Revisions Net=+16 | Growth EPS=+43.3% | Growth Revenue=+14.8%
EPS next Year (2027-06-30): EPS=6.34 | Chg30d=+0.450 | Revisions Net=+13 | Growth EPS=+25.4% | Growth Revenue=+14.0%
Additional Sources for COHR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle